Validation of three BRCA1/2 mutation-carrier probability models Myriad, BRCAPRO and BOADICEA in a population-based series of 183 German families.
about
Performance of BRCA1/2 mutation prediction models in male breast cancer patients.Breast cancer risk models: a comprehensive overview of existing models, validation, and clinical applications.Comparison between CaGene 5.1 and 6.0 for BRCA1/2 mutation prediction: a retrospective study of 150 BRCA1/2 genetic tests in 517 families with breast/ovarian cancer.
P2860
Validation of three BRCA1/2 mutation-carrier probability models Myriad, BRCAPRO and BOADICEA in a population-based series of 183 German families.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Validation of three BRCA1/2 mu ...... series of 183 German families.
@ast
Validation of three BRCA1/2 mu ...... series of 183 German families.
@en
type
label
Validation of three BRCA1/2 mu ...... series of 183 German families.
@ast
Validation of three BRCA1/2 mu ...... series of 183 German families.
@en
prefLabel
Validation of three BRCA1/2 mu ...... series of 183 German families.
@ast
Validation of three BRCA1/2 mu ...... series of 183 German families.
@en
P2093
P2860
P1433
P1476
Validation of three BRCA1/2 mu ...... series of 183 German families.
@en
P2093
A Rosenberger
M Shoukier
S M Schneegans
P2860
P2888
P304
P356
10.1007/S10689-011-9498-Y
P577
2012-06-01T00:00:00Z